Interim Report January-September 2016

Oriola-KD Corporation published the interim report 1 January - 30 September 2016 on Thursday, 20 October 2016 at 8.30 a.m.

President and CEO Eero Hautaniemi:

The third quarter invoicing in the Services business grew in line with the market, and profitability developed well in all operating countries. In the Consumer business our growth was weaker, but the sales mix continued to develop positively. We have established eight new pharmacies this year, and there are some to be opened in the fourth quarter as well. The profitability of the Consumer business declined due to the establishment costs.

We developed Oriola-KD according to our strategy; the acquisition of PharmaService complemented the Healthcare business with dose dispensing in Finland, and the acquisition of Farenta strengthened our Services offering to pharmacies and pharmaceutical companies.

Interim Report Q3/2016